Skip to main content

Chronic Kidney Disease in Non-renal Solid Organ Transplantation

  • Chapter
  • First Online:
Approaches to Chronic Kidney Disease

Abstract

Acute and chronic kidney diseases (AKI and CKD) are frequently seen in non-renal solid organ transplant (NR-SOT) recipients. Assessing kidney function in this population remains a challenge as estimates of GFR are based on serum creatinine, which can be falsely low in these patients due to sarcopenia. Using CKD-EPI cystatin-C based equation to assess eGFR can mitigate this problem, but it is not always used due to lack of availability and costs. In addition to calcineurin inhibitor use, numerous peri-transplant factors also contribute to the development of AKI and CKD among NR-SOT recipients. Renoprotective strategies and management of CKD and its complications among NR-SOT recipients should follow general expert guidelines. Among liver transplant candidates, guidelines exist for simultaneaous liver-kidney transplant and rescue kidney transplant for those who undergo liver transplant alone. At the time of writing, no guidelines exist for combined heart-kidney transplant. A multidisciplinary approach with open communication between transplant teams and a nephrologist is imperative to the care of NR-SOT recipients with kidney dysfunction.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Transplant trends. UNOS. Accessed 3 Dec 2019. https://unos.org/data/transplant-trends/.

  2. Wyatt CM, Arons RR. The burden of acute renal failure in nonrenal solid organ transplantation. Transplantation. 2004;78(9):1351–5. https://doi.org/10.1097/01.tp.0000140848.05002.b8.

    Article  PubMed  Google Scholar 

  3. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, Arndorfer J, Christensen L, Merion RM. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003;349(26):2563–5. https://doi.org/10.1056/nejm200312253492617.

    Article  Google Scholar 

  4. Kidney Disease: Improving Global Outcomes (KDIGO). Clinical practice guideline for the evaluation and management of the chronic kidney disease (CKD). 2012. https://kdigo.org/guidelines/ckd-evaluation-and-management/.

  5. Feehally J. Comprehensive clinical nephrology. Edinburgh: Elsevier; 2019.

    Google Scholar 

  6. Broekroelofs J, Stegeman C, Navis G, Haan JD, Bij WVD, Boer WD, de Zeeuw D, Jong PD. Creatinine-based estimation of rate of long-term renal function loss in lung transplant recipients. Which method is preferable? J Heart Lung Transplant. 2000;19(3):256–62. https://doi.org/10.1016/s1053-2498(99)00133-3.

    Article  CAS  PubMed  Google Scholar 

  7. Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl. 2004;10(2):301–9. https://doi.org/10.1002/lt.20017.

    Article  PubMed  Google Scholar 

  8. Bloom RD, Reese PP. Chronic kidney disease after nonrenal solid-organ transplantation. J Am Soc Nephrol. 2007;18(12):3031–41. https://doi.org/10.1681/asn.2007040394.

    Article  CAS  PubMed  Google Scholar 

  9. Ishani A, Erturk S, Hertz MI, Matas AJ, Savik K, Rosenberg ME. Predictors of renal function following lung or heart-lung transplantation. Kidney Int. 2002;61(6):2228–34. https://doi.org/10.1046/j.1523-1755.2002.00361.x.

    Article  PubMed  Google Scholar 

  10. Myers BD, Newton L. Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury. J Am Soc Nephrol. 1991;2(Suppl):S45–52.

    Article  CAS  Google Scholar 

  11. O’Riordan A, Wong V, McCormick PA, Hegarty JE, Watson AJ. Chronic kidney disease post-liver transplantation. Nephrol Dial Transplant. 2006;21:2630–6.

    Article  Google Scholar 

  12. Platz K-P, Mueller AR, Blumhardt G, Bachmann S, Bechstein WO, Kahl A, Neuhaus P. Nephrotoxicity following orthotopic liver transplantation: a comparison between cy- closporine and FK506. Transplantation. 1994;58:170–8.

    Article  CAS  Google Scholar 

  13. Mccauley J, Thiel DHV, Starzl TE, Puschett JB. Acute and chronic renal failure in liver transplantation. Nephron. 1990;55(2):121–8. https://doi.org/10.1159/000185938.

    Article  CAS  PubMed  Google Scholar 

  14. Srinivas TR, Stephany BR, Budev M, Mason DP, Starling RC, Miller C, Goldfarb DA, Flechner SM, Poggio ED, Schold JD. An emerging population: kidney transplant candidates who are placed on the waiting list after liver, heart, and lung transplantation. Clin J Am Soc Nephrol. 2010;5(10):1881–6. https://doi.org/10.2215/cjn.02950410.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Guitard J, Ribes D, Kamar N, Cointault O, Lavayssiere L, Esposito L, Rostaing L, Muscari F, Suc B, Peron JM. Predictive factors for chronic renal failure one year after orthotopic liver transplantation. Ren Fail. 2006;28:419–25.

    Article  Google Scholar 

  16. Canales M, Youssef P, Spong R, Ishani A, Savik K, Hertz M, Ibrahim HN. Predictors of chronic kidney disease in long-term survivors of lung and heart-lung transplantation. Am J Transplant. 2006;6:2157–63.

    Article  CAS  Google Scholar 

  17. Freedman BI, Moxey-Mims M. The APOL1 long-term kidney transplantation outcomes network—APOLLO. Clin J Am Soc Nephrol. 2018;13(6):940–2. https://doi.org/10.2215/cjn.01510218.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Bloom R, Doyle A. Kidney disease after heart and lung transplantation. Am J Transplant. 2006;6(4):671–9. https://doi.org/10.1111/j.1600-6143.2006.01248.x.

    Article  CAS  PubMed  Google Scholar 

  19. Nadkarni GN, Chauhan K, Patel A, Saha A, Poojary P, Kamat S, Patel S, Ferrandino R, Konstantinidis I, Garimella PS, Menon MC, Thakar CV. Temporal trends of dialysis requiring acute kidney injury after orthotopic cardiac and liver transplant hospitalizations. BMC Nephrol. 2017;18(1) https://doi.org/10.1186/s12882-017-0657-8.

  20. Ruggenenti P, Perico N, Mosconi L, Gaspari F, Benigni A, Amuchastegui CS, Bruzzi I, Remuzzi G. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int. 1993;43(3):706–11. https://doi.org/10.1038/ki.1993.101.

    Article  CAS  PubMed  Google Scholar 

  21. Thomas LD, Vilchez RA, White ZS, Zanwar P, Milstone AP, Butel JS, Dummer S. A prospective longitudinal study of polyomavirus shedding in lung transplant recipients. J Infect Dis. 2007;195:442–9.

    Article  CAS  Google Scholar 

  22. Randhawa P, Uhrmacher J, Pasculle W, Vats A, Shapiro R, Eghtsead B, Weck K. A comparative study of BK and JC virus infections in organ transplant recipients. J Med Virol. 2005;77:238–43.

    Article  Google Scholar 

  23. Muñoz P, Fogeda M, Bouza E, Verde E, Palomo J, Bañares R. Prevalence of BK virus replication among recipients of solid organ transplants. Clin Infect Dis. 2005;41(12):1720–5. https://doi.org/10.1086/498118.

    Article  PubMed  Google Scholar 

  24. Pham P-T, Pham P-M, Pham P-C. New onset diabetes after transplantation (NODAT): an overview. Diabetes Metab Syndr Obes. 2011:175. https://doi.org/10.2147/dmso.s19027.

  25. Hjelmesth J, Hartmann A, Kofstad J, Stenstrm J, Leivestad T, Egeland T, Fauchald P. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age 1. Transplantation. 1997;64(7):979–83. https://doi.org/10.1097/00007890-199710150-00008.

    Article  Google Scholar 

  26. Bloom RD, Crutchlow MF. New-onset diabetes mellitus in the kidney recipient: diagnosis and management strategies. Clin J Am Soc Nephrol. 2008;3(Supplement 2) https://doi.org/10.2215/cjn.02650707.

  27. Drachenberg CB, Klassen DK, Wiland A, Weir MR, Fink JC, Cangro CB, Blahut S, Papadimitriou JC. Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation. 1999;67(7) https://doi.org/10.1097/00007890-199904150-00834.

  28. Nadim MK, Forni LG, Bihorac A, Hobson C, Koyner JL, Shaw A, Arnaoutakis GJ, Ding X, Engelman DT, Gasparovic H, Gasparovic V, Herzog CA, Kashani K, Katz N, Liu KD, Mehta RL, Ostermann M, Pannu N, Pickkers P, Price S, Ricci Z, Rich JB, Sajja LR, Weaver FA, Zarbock A, Ronco C, Kellum JA. Cardiac and vascular surgery–associated acute kidney injury: the 20th international consensus conference of the ADQI (Acute Disease Quality Initiative) group. J Am Heart Assoc. 2018;7(11) https://doi.org/10.1161/jaha.118.008834.

  29. Rocha PN, Rocha AT, Palmer SM, Davis RD, Smith SR. Acute renal failure after lung transplantation: incidence, predictors and impact on perioperative morbidity and mortality. Am J Transplant. 2005;5(6):1469–76. https://doi.org/10.1111/j.1600-6143.2005.00867.x.

    Article  PubMed  Google Scholar 

  30. Lin J, Valeri AM, Markowitz GS, Dagati VD, Cohen DJ, Radhakrishnan J. Angiotensin converting enzyme inhibition in chronic allograft nephropathy. Transplantation. 2002;73(5):783–8. https://doi.org/10.1097/00007890-200203150-00022.

    Article  CAS  PubMed  Google Scholar 

  31. Artz MA. Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy. Nephrol Dial Transpl. 2004;19(11):2852–7. https://doi.org/10.1093/ndt/gfh462.

    Article  CAS  Google Scholar 

  32. Gogia A, Kakar A, Gangwani A. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. Curr Med Res Pract. 2019;9(4):164. https://doi.org/10.1016/j.cmrp.2019.07.012.

    Article  Google Scholar 

  33. Cassuto JR, Reese PP, Sonnad S, Bloom RD, Levine MH, Olthoff KM, Shaked A, Abt P. Wait list death and survival benefit of kidney transplantation among nonrenal transplant recipients. Am J Transplant. 2010;10(11):2502–11. https://doi.org/10.1111/j.1600-6143.2010.03292.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Simultaneous Liver-Kidney Allocation (SLK) policy changes now in effect. UNOS, June 6, 2019. https://unos.org/news/simultaneous-liver-kidney-allocation-slk-policy-changes-now-in-effect/.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anju Yadav .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mejia, C., Yadav, A. (2022). Chronic Kidney Disease in Non-renal Solid Organ Transplantation. In: McCauley, J., Hamrahian, S.M., Maarouf, O.H. (eds) Approaches to Chronic Kidney Disease . Springer, Cham. https://doi.org/10.1007/978-3-030-83082-3_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-83082-3_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-83081-6

  • Online ISBN: 978-3-030-83082-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics